Navigation Links
China Cord Blood Corporation Reports Financial Results for the First Quarter of Fiscal 2012
Date:8/29/2011

HONG KONG, Aug. 29, 2011 /PRNewswire-Asia-FirstCall/ -- China Cord Blood Corporation (NYSE: CO) ("CCBC" or the "Company"), China's leading provider of cord blood collection, laboratory testing, hematopoietic stem cell processing, and stem cell storage services, today announced its preliminary unaudited financial results for the first quarter of fiscal year 2012, which ended June 30, 2011.

First Quarter of Fiscal 2012Highlights

  • Revenue for the first quarter of fiscal 2012 increased by 22.0% to RMB87.5 million ($13.5 million) from RMB71.7 million in the prior year period.
  • New subscriber sign-ups and accumulated subscriber base reached 12,828 and 198,658, respectively.
  • Gross profit increased by 24.1% to RMB67.6 million ($10.5 million) from RMB54.4 million from the prior year period.
  • Gross margin was 77.3%, compared to 75.9% for the prior year period.
  • Operating income increased by 31.7% to RMB30.8 million ($4.8 million) from RMB23.4 million for the prior year period.
  • Net income attributable to shareholders, inclusive of dividend income of RMB7.2 million ($1.1 million) from Shandong Cord Blood Bank and effect of the preferential tax treatment obtained by the Guangdong subsidiary resulting in a discrete tax benefit of RMB10.2 million ($1.6 million), was RMB40.0 million ($6.2 million), compared to RMB17.6 million in the prior year period.

  • "Our first quarter delivered strong financial performance driven by sustained growth in subscriber demand year-over-year following the upward price adjustment implemented in April 2011," stated Ms. Zheng, Chairperson and Chief Executive Officer of CCBC. "Our strategy to develop a strong sales network while broadening our commercial reach has built a widely-recognized brand and an easily accessible network that will greatly facilitate our efforts to attract new su
    '/>"/>

    SOURCE China Cord Blood Corporation
    Copyright©2010 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7 8 9 10

    Related biology technology :

    1. China Cord Blood Corporation to Report First Quarter Fiscal 2012 Financial Results
    2. Industrial Biotechnology China News 1106
    3. China Agri-Business Acquired Management and Operation Rights of Shaanxi Qinfeng Agrochemical Inc. in Xian, China
    4. China-Biotics, Inc. Receives NASDAQ Delisting Notification
    5. China-Biotics Provides Update
    6. China Cord Blood Corporation Reports Financial Results for the Fourth Quarter and Full Year of Fiscal 2011
    7. Reportlinker Adds Industrial Biotechnology China News 1105 - Annual Subscription
    8. NIST contests in China put next-gen robot technologies to the test
    9. Reportlinker Adds Future of White Biotechnology in China
    10. China Cord Blood Corporation to Report Fourth Quarter and Full Year Fiscal 2011 Financial Results
    11. MicroConstants China Receives Endorsement of OECD GLP Compliance
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:3/2/2015)... Md. , March 2, 2015 ... -based biotechnology company focusing on the research ... next generation antibody agents based upon a novel ... a 2015 Life Sciences Impact Grant Award from ... The grant, created by MCDED, is awarded to ...
    (Date:3/2/2015)... CORAL SPRINGS, Florida , March 2, 2015 ... products, science-based pharmaceuticals and healthy whole food nutrition ... for treatments of lifestyle related disorders such as ... illnesses and health concerns.  Nutraceutical and Biotech Companies ... RIBT ), Amira Nature Foods Ltd. (NYSE: ...
    (Date:3/2/2015)... 2015 VG Life Sciences, Inc., (OTCQB: ... and infectious diseases, announced that the U.S. Patent ... new composition of matter patent covering methods for ... CLIP. U.S. Patent No. 8957031 ... Sciences, VG1177, a synthetic peptide which has the ...
    (Date:3/2/2015)... March 02, 2015 Outside GC, the ... announced the addition of Debbie Casey as a member ... the healthcare space. , Debbie has spent ... which with Fresenius Medical Care North America in both ... extensive experience to work with Outside GC’s growing list ...
    Breaking Biology Technology:VLP Therapeutics Wins the 2015 Life Sciences Impact Grant Award from the Montgomery County Department of Economic Development 2Clinical Studies & Research Substantiate Claims That Company's Targeted Healthy Nutritional Products Promote Healthy Lipids, Glucose & Insulin Levels 2Clinical Studies & Research Substantiate Claims That Company's Targeted Healthy Nutritional Products Promote Healthy Lipids, Glucose & Insulin Levels 3Clinical Studies & Research Substantiate Claims That Company's Targeted Healthy Nutritional Products Promote Healthy Lipids, Glucose & Insulin Levels 4Clinical Studies & Research Substantiate Claims That Company's Targeted Healthy Nutritional Products Promote Healthy Lipids, Glucose & Insulin Levels 5Clinical Studies & Research Substantiate Claims That Company's Targeted Healthy Nutritional Products Promote Healthy Lipids, Glucose & Insulin Levels 6Clinical Studies & Research Substantiate Claims That Company's Targeted Healthy Nutritional Products Promote Healthy Lipids, Glucose & Insulin Levels 7VG Life Sciences Granted Key Composition Of Matter Patent 2VG Life Sciences Granted Key Composition Of Matter Patent 3Outside GC Expands Healthcare Team 2
    ... National Stem,Cell Holding, Inc. (OTC: NHGI) today announced ... at the 16th Annual International,World Congress on Anti-Aging ... -- 19, 2008. Dr. Kenneth Steiner, MD, MBA ... Dr. Steiner will introduce the company,s first,commercial line ...
    ... July 17 XTL,Biopharmaceuticals Ltd. (Nasdaq: XTLB ... ("AGM") and Extraordinary General Meeting ("EGM") scheduled,for today ... 2008 at,4:00pm and 4:30 pm Israel time, respectively., ... Ltd. ("XTL") is engaged in the development of,therapeutics ...
    ... BEDFORD, Mass. and MADISON, Wis., July 17 ,Hologic, Inc. ... (Nasdaq:,TWTI) ("Third Wave"), today jointly announced the expiration of ... wholly-owned subsidiary Thunder,Tech Corp. (the "Purchaser") for all outstanding ... period expired, as scheduled, at 12:00,midnight, New York City ...
    Cached Biology Technology:National Stem Cell Holding, Inc. (Ticker NHGI) Subsidiary Proteoderm, Inc. Debuts Cosmoceutical Line at the 2008 World Congress on Anti-Aging Medicine 2Hologic, Inc. Accepts Shares of Third Wave Technologies, Inc. in Tender Offer and Commences Subsequent Offering Period 2Hologic, Inc. Accepts Shares of Third Wave Technologies, Inc. in Tender Offer and Commences Subsequent Offering Period 3Hologic, Inc. Accepts Shares of Third Wave Technologies, Inc. in Tender Offer and Commences Subsequent Offering Period 4Hologic, Inc. Accepts Shares of Third Wave Technologies, Inc. in Tender Offer and Commences Subsequent Offering Period 5
    (Date:3/3/2015)... 3, 2015 Cryoport, Inc. (OTCBB: ... cryogenic logistics solutions for the life sciences ... cell lines, clinical research organizations, vaccine manufacturers, ... the expansion of its relationship with ... Hutch") Clinical Research Division with the inclusion ...
    (Date:3/2/2015)... Calif. , March 2, 2015 ... leading developer of human interface solutions, today announced ... that is designed to enable rapid and secure ... ID™ module for gaming is a turnkey solution ... the ability to quickly integrate fingerprint ID solutions ...
    (Date:3/2/2015)... March 2, 2015  Businesses have a new ... company Tharon Rankins Enterprises has announced the launch ... ultra-safe way for businesses to protect their customers, ... Beconux is a biometric transaction ... Functioning similarly to an ATM machine, the new ...
    Breaking Biology News(10 mins):Cryoport, Inc. Expands Support of Fred Hutchinson Cancer Research Center's Clinical Research Division 2Cryoport, Inc. Expands Support of Fred Hutchinson Cancer Research Center's Clinical Research Division 3Synaptics Unveils New Fingerprint ID Solution for Gamers 2Synaptics Unveils New Fingerprint ID Solution for Gamers 3Personal Data Protection Company Launches New Product 2
    ... Bethesda, Md. (July 27, 2011)Roux-en-Y gastric bypass, the most ... is currently considered the most effective therapy for morbid ... stomach is reduced to a small pouch and connected ... massive amounts of weight. However, the reasons behind this ...
    ... Md. "Brain cap" technology being developed at the ... into motion. Associate Professor of Kinesiology Jos ,Pepe, L. ... cap with neural interface software that soon could be ... and even digital avatars. "We are on track ...
    ... patients may view their tumors as parasites taking over their ... Duesberg, a molecular and cell biology professor at the University ... said. Each one is a new species that, like most ... independently and often to the detriment of its host. ...
    Cached Biology News:Study suggests weight loss from gastric bypass may be partly due to dietary fat aversion 2Study suggests weight loss from gastric bypass may be partly due to dietary fat aversion 3UMD brain cap technology turns thought into motion 2UMD brain cap technology turns thought into motion 3UMD brain cap technology turns thought into motion 4UMD brain cap technology turns thought into motion 5Are cancers newly evolved species? 2Are cancers newly evolved species? 3Are cancers newly evolved species? 4Are cancers newly evolved species? 5
    Human peripheral blood CD19+ B cells, For immunohistochemistry (IHC) Cell Chip with Human Peripheral Blood Monocytes, B Cells, NK Cells and Stem Cells...
    Human peripheral blood basophils, For immunohistochemistry (IHC) Cell Chip with Human Peripheral Blood Granulocytes...
    Umbilical cord blood CD4+ T cells, For immunohistochemistry (IHC) Cell Chip with Human Umbilical Cord Blood MNCs and T Cells...
    ... an anodized aluminum, solvent-resistant block specially designed ... efficient thermal transfer to samples within the ... HT96 Isothermal Block replaces Cat. No. 71031-3, ... for compatibility with robotic applications. The new ...
    Biology Products: